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A 24 year old African-American male with a history of
AIDS with a recent CD4 count of 57/uL, is admitted to
the hospital with substernal chest pain and shortness of
breath for the past two weeks. Dyspnea is mostly on
exertion, and the patient denied productive cough or
hemoptysis, fevers, chills, or night sweats. Three weeks
prior to presentation, the patient underwent esopha-
gogastroduodenoscopy, which revealed an esophageal
ulcer. Biopsies did not show any specific pathology and
cultures were negative. Outpatient medications include
prednisone, rabeprazole, fluconazole, clarithromycin,
and ethambutol, bactrim. 
Vitals on admission were as follows: temperature 97.2,
pulse 80/min, and respiration rate 26/min. On physical
exam, no crackles or wheezing were found.
Computerized tomography scan of the chest revealed
multiple bilateral nodules, without pleural effusions or
mediastinal/hilar lymphadenopathy. Bronchoscopy was
performed with transbronchial biopsy; cultures obtained
were negative. Transbronchial lung biopsy showed an
interstitial infiltrate of mononuclear cells, predominantly
lymphocytes, consistent with a diagnosis of nonspecific
interstitial pneumonitis. The patient was subsequently
referred to infectious disease clinic for highly active
antiretroviral therapy.
Nonspecific Interstitial Pneumonitis
Interstitial pneumonitis in HIV-infected patients is most
commonly caused by Pneumocystis carinii (PCP). PCP
occurs in up to 50% of patients with acquired immune
deficiency syndrome (AIDS) in the last 6 months of their
lives1. Sputum induction for diagnosis of PCP is
associated with variable sensitivity of 50 to 95%.2-3.
Because the test can have a negative predictive value as
low as 39%, the absence of Pneumocystis carinii in
induced sputum does not reliably exclude the diagnosis
of PCP. Other patients may be too ill to undergo
bronchoscopy. Thus, many HIV-infected patients with
pneumonitis are empirically treated without a confirmed
diagnosis3. In some cases, however, pneumonitis cannot
be ascribed either to known infectious agents or to
malignancy. These disorders are believed to be
inflammatory in origin and are grouped into two entities:
lymphoid interstitial pneumonitis (LIP) and nonspecific
interstitial pneumonitis (NSIP)4. In one study on 351
HIV-positive patients with pneumonitis, NSIP was the
most common histologic diagnosis in patients without
PCP3. Because treatment and prognosis of PCP and NSIP
are different, it is important to differentiate these entities.
Nonspecific interstitial pneumonitis (NSIP) is a term
applied to conditions in which there are abnormal
mononuclear cell infiltrates of the lung without other
explanations for the abnormality, including previous
infection, malignancy, LIP or exposure to pulmonary
toxic drugs4-7.
Prevalence
NSIP occurs in 5 to 11% of HIV-infected adults who
present with respiratory disease3-6. NSIP was detected in
24% of 67 symptomatic patients without PCP, using
bronchoalveolar lavage (BAL) and transbronchial biopsy
(3 NSIP prevalence has been reported to be as high as
38%. In this study, 41 out of 110 AIDS patients had
NSIP3,6. Subclinical NSIP can also occur. Evidence of
NSIP was found in 50% asymptomatic HIV-infected
patients with normal chest radiograph and CD4 count
below 200 cells/mm3 on transbronchial biopsies6.
Clinical Manifestations
Symptoms include dyspnea with or without cough, fever,
and hypoxia4,8. Certain clinical descriptors are helpful in
distinguishing NSIP from PCP. Patient with NSIP are
more likely to have less advanced HIV infection with
higher body mass, serum albumin levels, and CD4
counts3,8. These patients tend to have less lung
inflammation, normal LDH values, and fewer involved
lobes on chest radiographs (CXR)3. CXR findings may
vary from normal to increased interstitial markings.
Reticulonodular infiltrates have been reported in
occasional cases5-6,9. Mediastinal and hilar
lymphadenopathy or associated pleural effusions have
not been reported in NSIP.
Pathology
NSIP is defined by the presence of chronic interalveolar
septal inflammation in the absence of a specific
microorganism, identified through standard
histopathologic, histochemical, cytologic, and culture
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techniques (methenamine silver for P. carinii, Ziel-
Neelsen method for mycobacteria, nuclear inclusions for
CMV pneumonia)3. Pathologic findings include
interstitial infiltration predominantly consisting of
lymphocytes and plasma cells, fibrosis, edema,
pneumocyte hyperplasia, alveolar hyaline membranes,
bronchial inflammation, and thickened alveolar septae3-4.
In one retrospective review of seven patient with NSIP,
interstitial pneumonitis consisted of a patchy
lymphocytic infiltrates composed of B cells in focal
aggregates and T cells in a more diffuse distribution. The
T cell population was a mixture of CD4 and CD8
lymphocytes. These findings contrast with the more
extensive infiltrates of predominantly CD8 lymphocytes
seen in lymphocytic interstitial pneumonitis (LIP),
which occur mainly in children8.
Etiology
The etiology of NSIP is uncertain. The cytokine profile
of BAL fluid samples from patients with NSIP differs
from that with PCP, suggesting that NSIP is a distinct
entity3,10. In 15 NSIP patients, in-situ hybridization did
not show evidence of Epstein-Barr virus (EBV) or
Cytomegalovirus (CMV) infection. Whether HIV causes
NSIP is uncertain. Polymerase chain reaction (PCR)
testing for HIV gag and env DNA is usually positive in
NISP, but also positive in HIV control patients with
normal lung histology3. The role of Human herpes virus
type 6 (HHV-6) is also unclear.
Course and Therapy
NSIP runs a subacute and generally benign course.
Spontaneous improvement in 7-10 days has been
reported3. There is no published data available on
treatment modalities, although some patients have
anecdotally responded to oral steroids. Long-term survival
is less than three years, prognosis primarily determined
by other infective or neoplastic complications. NSIP does,
however, appear to mark a clinical decline in the
progression of HIV infection. The role of HAART in the
treatment of this disorder is unknown4,8.
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